Guizhou Yibai Pharmaceutical Co., Ltd. (SHA:600594)

SHA:600594 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	457.07	521.01	699.47	592.36	379.63	617.43
Short-Term Investments	-	20	-	-	-	100.88
Cash & Short-Term Investments	457.07	541.01	699.47	592.36	379.63	718.31
Cash Growth	-40.69%	-22.66%	18.08%	56.04%	-47.15%	-32.60%
Accounts Receivable	537.54	528.94	692.32	722.23	698.66	976.28
Other Receivables	21.26	38.88	53.84	56.42	38.42	42.48
Receivables	558.81	567.82	746.16	778.65	737.07	1,019
Inventory	592.28	607.77	586.65	625.08	554.63	498.36
Other Current Assets	77.13	33.43	36.87	44.54	48.65	48.75
Total Current Assets	1,685	1,750	2,069	2,041	1,720	2,284
Property, Plant & Equipment	1,618	1,648	1,755	1,827	1,709	1,419
Long-Term Investments	36.29	36.41	36.66	37.46	38.27	41.16
Goodwill	131.26	131.26	164.04	164.04	777.66	631.73
Other Intangible Assets	315.6	319.56	330.89	362.03	378.54	341.97
Long-Term Deferred Tax Assets	93.37	90.34	55.58	229.96	202.28	191.32
Long-Term Deferred Charges	97.57	103.47	123.13	145.72	169.81	172.7
Other Long-Term Assets	17.47	20.58	62.42	63.17	72.4	144.16
Total Assets	3,995	4,100	4,597	4,870	5,068	5,226
Accounts Payable	113.93	117.98	124.54	133.25	108.47	84.72
Accrued Expenses	29.47	57.79	72.43	103.61	86.57	86.39
Short-Term Debt	405.95	380.93	446.05	537.11	454.45	745.55
Current Portion of Long-Term Debt	213.5	227.68	115.05	162.15	120.15	345
Current Portion of Leases	2.77	8.98	13.97	15.37	9.16	9.15
Current Income Taxes Payable	29.49	8.85	7.54	21.07	47.42	41.98
Current Unearned Revenue	24.46	27.12	29.52	67.51	54.15	23.05
Other Current Liabilities	94.76	119.68	120.49	132.64	199.01	200.21
Total Current Liabilities	914.35	949.01	929.59	1,173	1,079	1,536
Long-Term Debt	250	307.52	387.22	343.04	315.93	94.38
Long-Term Leases	20.77	26.78	30.36	29.3	12.41	-
Long-Term Unearned Revenue	97.3	94.64	106.31	100.18	67.6	41.38
Long-Term Deferred Tax Liabilities	34.03	34.74	37.44	33.9	30.26	25.69
Other Long-Term Liabilities	83.77	80.9	88.07	0.65	-	65.75
Total Liabilities	1,400	1,494	1,579	1,680	1,506	1,763
Common Stock	791.93	791.93	791.93	791.93	791.93	791.93
Additional Paid-In Capital	653.84	653.84	653.84	733.84	766.15	768.39
Retained Earnings	1,059	1,069	1,438	1,518	1,944	1,803
Treasury Stock	-25	-25	-	-	-	-
Comprehensive Income & Other	0.45	0.45	0.65	0.99	1.19	1.73
Total Common Equity	2,480	2,490	2,884	3,044	3,503	3,365
Minority Interest	114.31	116.35	133.81	145.85	59.25	97.96
Shareholders' Equity	2,595	2,606	3,018	3,190	3,562	3,463
Total Liabilities & Equity	3,995	4,100	4,597	4,870	5,068	5,226
Total Debt	893	951.89	992.65	1,087	912.11	1,194
Net Cash (Debt)	-435.92	-410.88	-293.18	-494.6	-532.48	-475.77
Net Cash Per Share	-0.55	-0.52	-0.37	-0.62	-0.67	-0.60
Filing Date Shares Outstanding	784.39	784.39	791.93	791.93	791.93	791.93
Total Common Shares Outstanding	784.39	784.39	791.93	791.93	791.93	791.93
Working Capital	770.94	801.01	1,140	867.92	640.59	748.12
Book Value Per Share	3.16	3.17	3.64	3.84	4.42	4.25
Tangible Book Value	2,034	2,039	2,390	2,518	2,347	2,391
Tangible Book Value Per Share	2.59	2.60	3.02	3.18	2.96	3.02
Buildings	-	1,911	1,865	1,686	1,326	1,266
Machinery	-	924.43	933.15	906.77	809.92	699.97
Construction In Progress	-	0.7	4.99	145.94	472.4	240.49

Source: S&P Global Market Intelligence. Standard template. Financial Sources.